Taken together, using WGCNA and comprehensive analyses, this study provides a better understanding of the role of biomarkers EIF3H, RAD51C, FAM162A, BLVRA, ATP6V1H, and BRAF and provides a biological basis for further studies on AD progression. Here, FAM162A is linked to Alzheimer disease.